Media reports about vaccine hesitancy could contribute to the problem
Alongside logistical and supply issues, vaccine hesitancy has been a notable hurdle in Australia’s troubled vaccine rollout.
The news the Australian Technical Advisory Group on Immunisation (ATAGI) now recommends Pfizer over AstraZeneca for everyone under 60, owing to a rare blood clotting disorder, is proving another blow to vaccine...




